Revvity RVTY
NYSE RVTY
$146.80 +1.07 (+0.73%)
As of: Sep 17, 2026 · 3:59 PM EDT

Revvity (RVTY) Liabilities and Shareholders Equity (2010 - 2026)

Revvity's (RVTY) quarterly Liabilities and Shareholders Equity came in at $12.0 billion in Q3 2026, down 2.56% on a YoY basis from $12.4 billion in Q3 2025, and little changed quarter-over-quarter from $12.0 billion in Q2 2026.

Analysis

Revvity (RVTY) Liabilities and Shareholders Equity (2010 - 2026) Analysis & Trends

Revvity (RVTY) has reported Liabilities and Shareholders Equity for 17 consecutive years, with $12.0 billion the latest figure, recorded in Q3 2026.

  • For the quarter ending Q3 2026, Liabilities and Shareholders Equity fell 2.56% year-over-year to $12.0 billion; the trailing twelve-month figure through Jul 2026 stood at $48.3 billion (down 3.08% YoY), and the FY2025 full-year result was $12.2 billion, down 1.81% from the prior year.
  • Liabilities and Shareholders Equity was little changed at $12.0 billion in Q3 2026 per RVTY's latest filing, from $12.0 billion in the prior quarter.
  • Across five years, Liabilities and Shareholders Equity topped out at $15.0 billion in Q1 2022 and bottomed at $12.0 billion in Q2 2026.
  • Historically, Liabilities and Shareholders Equity has averaged $13.3 billion across 5 years, with a median of $13.4 billion in 2024.
  • The sharpest annual moves came in 2022 and 2024: Liabilities and Shareholders Equity jumped 88.44% in 2022, then retreated 8.64% in 2024.
  • Over 5 years, Liabilities and Shareholders Equity stood at $13.8 billion in 2022, then decreased by 1.87% to $13.6 billion in 2023, then decreased by 8.64% to $12.4 billion in 2024, then declined by 1.81% to $12.2 billion in 2025, then decreased by 1.01% to $12.0 billion in 2026.
  • According to Business Quant data, Liabilities and Shareholders Equity over the past three periods registered $12.0 billion, $12.0 billion, and $12.2 billion for Q3 2026, Q2 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Thermo Fisher Scientific 241.68 Bn 237.61 Bn 8.34 Bn 113.17 Bn
2 Danaher 147.34 Bn 142.99 Bn 3.61 Bn 92.37 Bn
3 Agilent Technologies 43.34 Bn 41.59 Bn 1.04 Bn 13.97 Bn
4 Illumina 34.58 Bn 33.41 Bn 770.00 Mn 6.65 Bn
5 Revvity 16.31 Bn 15.29 Bn 416.87 Mn 12.05 Bn
6 Bio-Techne 11.28 Bn 11.01 Bn 211.39 Mn 2.59 Bn
7 Bio-Rad Laboratories 10.16 Bn 8.54 Bn 345.80 Mn 10.25 Bn
8 Repligen 9.77 Bn 8.75 Bn 110.04 Mn 2.95 Bn
9 10x Genomics 9.45 Bn 8.90 Bn 112.50 Mn 1.03 Bn
10 Bruker 9.26 Bn 9.04 Bn 416.00 Mn 6.05 Bn
Historic Data

Historic Data

Download Data
DateValue
Jul 5, 2026 12.05 Bn
Apr 5, 2026 12.00 Bn
Dec 28, 2025 12.17 Bn
Sep 28, 2025 12.14 Bn
Jun 29, 2025 12.36 Bn
Mar 30, 2025 12.36 Bn
Dec 29, 2024 12.39 Bn
Sep 29, 2024 12.77 Bn
Jun 30, 2024 13.42 Bn
Mar 31, 2024 13.43 Bn
Dec 31, 2023 13.56 Bn
Oct 1, 2023 13.42 Bn
Jul 2, 2023 14.22 Bn
Apr 2, 2023 14.64 Bn
Jan 1, 2023 14.13 Bn
Oct 2, 2022 13.82 Bn
Jul 3, 2022 14.19 Bn
Apr 3, 2022 14.85 Bn
Jan 2, 2022 15.00 Bn
Oct 3, 2021 14.90 Bn